SCHEMBL19081990

SCHEMBL19081990

c1cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc(-c2cc3sc4ccc5ccccc5c4c3c3oc4ccccc4c23)c1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP1A1 P04798 2/20 0.32
NPC1 O15118 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
CYP1B1 Q16678 1/20 0.32
GPR84 Q9NQS5 1/20 0.31
FYN P06241 1/20 0.31
MAPK3 P27361 1/20 0.31
AHR P35869 1/20 0.31
PAX8 Q06710 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
S1PR4 O95977 2/20 0.31
S1PR5 Q9H228 2/20 0.31
PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081818 0.93 TDP1 (0.35) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL19081603 0.86 NPC1 (0.37) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL19076843 0.84 ALOX5 (0.37) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL19081994 0.84 CYP1A1 (0.38) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL19081958 0.84 ABCG2 (0.33) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL17932141 0.84 ALOX5 (0.39) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL19082028 0.82 CYP1A1 (0.36) TDP1L3MBTL1ALOX5CYP1A2CYP1A1
SCHEMBL17945216 0.82 S1PR5 (0.35) ALOX5CYP1A2CYP1A1NPC1CYP2C9
SCHEMBL19081848 0.82 TDP1 (0.32) TDP1L3MBTL1CYP1A2CYP1A1NPC1
SCHEMBL19081598 0.82 TDP1 (0.36) TDP1L3MBTL1ALOX5CYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.